| Characteristic | Share of executives |
|---|---|
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
January 2026
Region
Europe, United States, APAC
Survey time period
August to September 2025
Number of respondents
500 executives
Special properties
250 organization across nine leading markets
Supplementary notes
Executives who agree with the statement that AI will transform biopharma R&D.Â
Citation formats









